`Filed: June 3, 2016
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC and PAR PHARMACEUTICAL, INC.
`
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`
`Patent Owner
`
`________________
`
`Case IPR2015-01903
`Patent 8,731,963
`________________
`
`JAZZ PHARMACEUTICALS, INC.’S EXHIBIT LIST AS OF
`June 3, 2016 PURSUANT TO 37 C.F.R. § 42.63(e)
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01903
`Patent 8,731,963
`Patent Owner’s Exhibit List
`
`
`
`
`EXHIBIT NO.
`Exhibit 2001
`
`Exhibit 2002
`
`Exhibit 2003
`
`Exhibit 2004
`Exhibit 2005
`Exhibit 2006
`Exhibit 2007
`Exhibit 2008
`Exhibit 2009
`
`Exhibit 2010
`
`Exhibit 2011
`
`Exhibit 2012
`
`Exhibit 2013
`
`DESCRIPTION
`Letter from Dr. Robert Temple, Director, ODE I, to Dr. Dayton
`T. Reardan, Orphan Medical, Inc. (July 17, 2002)
`Letter from Dr. Russell Katz, Director, Division of Neurology
`Products, ODE I, to Dr. Dayton T. Reardan, Orphan Medical,
`Inc. (Nov. 18, 2005)
`Hillory J. Farias and Samantha Reid Date-Rape Drug
`Prohibition Act of 2000, Pub. L. No. 106-172, §§ 2(5)-(6), 114
`Stat. 7, 7-8 (Feb. 18, 2000)
`146 Cong. Rec. H55-62 (daily ed. Jan. 31, 2000)
`Declaration of Joseph T. DiPiro, Pharm.D.
`Declaration of Bryan Bergeron, MD, FACMI
`October 8, 2015 Deposition of Dr. Robert J. Valuck
`October 9, 2015 Deposition of Dr. Robert J. Valuck
`Email correspondence between Patent Owner and Petitioners
`regarding overlapping issues with the REMS patents IPRs
`Merriam-Webster’s Collegiate Dictionary, 10th Edition 1997,
`definition of periodic
`File History Excerpt, U.S. Patent No. 7,668,730, Appeal Brief
`(filed July 18, 2007)
`January 22, 2016 Deposition of Dr. Bryan Bergeron in Par
`Pharmaceutical Inc. et al. v. Jazz Pharmaceuticals Inc.
`IPR2015-00548
`Orange Book Listing for Xyrem
`
`
`Date: June 3, 2016
`
`
`
`Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Evangeline Shih (Reg. No. 50,170)
` Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`
`
`
`Case IPR2015-01903
`Patent 8,731,963
`Patent Owner’s Exhibit List
`
`
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`evangelineshih@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`John V. Biernacki
`Reg. No. 40,511
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`General Tel: (216) 586-3939
`Direct Tel: (216) 586-7747
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`
`Attorneys for Jazz Pharmaceuticals, Inc.
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC and PAR PHARMACEUTICAL, INC.,
`
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`
`Patent Owner
`
`________________
`
`Case IPR2015-01903
`Patent 8,731,963
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certify that JAZZ
`
`PHARMACEUTICALS, INC.’S EXHIBIT LIST AS OF June 3, 2016 was
`
`served on June 3, 2016 by filing this document through the Patent Review
`
`Processing System, as well as e-mailing a copy to bradford.frese@arentfox.com,
`
`janine.carlan@arentfox.com, richard.berman@arentfox.com, and
`
`XYREM@arentfox.com.
`
`Date: June 3, 2016
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`Lead Counsel for
`Jazz Pharmaceuticals, Inc.